MedPath

INSTITUTE OF LIVER AND BILIARY SCIENCES

INSTITUTE OF LIVER AND BILIARY SCIENCES logo
🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal Varices

Not Applicable
Completed
Conditions
Liver Cirrhosis
Interventions
Drug: Standard Medical Treatment
First Posted Date
2021-09-27
Last Posted Date
2025-03-20
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
104
Registration Number
NCT05057572
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Liver and Splenic Stiffness in Predicting Esophageal Varices Needing Treatment in NASH Related Compensated Advanced Chronic Liver Disease.

Completed
Conditions
Chronic Liver Disease
Interventions
Other: No intervention
First Posted Date
2021-09-16
Last Posted Date
2023-06-06
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
200
Registration Number
NCT05044663
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New delhi, Delhi, India

Effect of Lockdown During COVID 19 Pandemic on Liver Disease and Metabolic Parameters.

Completed
Conditions
Liver Diseases
Interventions
Other: No intervention
First Posted Date
2021-08-31
Last Posted Date
2021-09-22
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
230
Registration Number
NCT05028842
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

To Evaluate the Safety and Efficacy of Preemptive Administration of Continuous Renal Replacement Therapy in Patients With Acute Liver Failure With Cerebral Edema

Not Applicable
Conditions
Acute Liver Failure
Interventions
Procedure: Continuous Renal Replacement Therapy (CRRT)
Other: Standard Medical Treatment
First Posted Date
2021-08-05
Last Posted Date
2021-08-17
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
60
Registration Number
NCT04991259
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Utility of Liver and Splenic Stiffness in Predicting Esophageal Varices in Patients With Acute on Chronic Liver Failure

Completed
Conditions
Acute-On-Chronic Liver Failure
Interventions
Other: No Intervention
First Posted Date
2021-07-30
Last Posted Date
2025-01-22
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
216
Registration Number
NCT04983108
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Incidence and Predictors of Bleeding Diathesis Development Due to DIC in Cirrhosis and ACLF Patients Undergoing CRRT

Conditions
Acute-On-Chronic Liver Failure
First Posted Date
2021-07-13
Last Posted Date
2021-07-13
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
40
Registration Number
NCT04960163
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Impact of Continuous Renal Replacement Therapy on Systemic Hemodynamics and Lactate Clearance in Critically Ill Cirrhotics With Septic Shock.

Conditions
Liver Cirrhosis
Interventions
Other: No intervention
First Posted Date
2021-07-02
Last Posted Date
2021-07-02
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
50
Registration Number
NCT04949178
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Sedation for Patients Undergoing Endoscopic Retrograde Cholangiopancreatography

Not Applicable
Completed
Conditions
Biliary Colic
Interventions
First Posted Date
2021-04-26
Last Posted Date
2021-04-26
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
90
Registration Number
NCT04860167
Locations
🇮🇳

Gaurav Sindwani, New Delhi, Delhi, India

Comparison of Bolus Versus Continuous Infusion of Terlipressin Cirrhotic Patients With Septic Shock.

Not Applicable
Conditions
Liver Cirrhosis
Interventions
Other: Standard of Care
First Posted Date
2021-03-29
Last Posted Date
2021-11-10
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
310
Registration Number
NCT04819568
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Evaluation of Albumin and Midodrine Versus Albumin Alone in Outcome of Refractory Ascites in Patients With Decompensated Cirrhosis.

Not Applicable
Conditions
Liver Cirrhosis
Interventions
Biological: Albumin
Other: Standard Medical Treatment
Other: Placebo
First Posted Date
2021-03-25
Last Posted Date
2021-06-15
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
200
Registration Number
NCT04816240
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

© Copyright 2025. All Rights Reserved by MedPath